← Back to catalogue

Sickle-Heme

FDA UDI

Class II (US FDA UDI)

by Great Lakes Diagnostics, Inc.

Identity

Trade Name
Sickle-Heme FDA UDI
Generic Name
Haemoglobin S (HbS) IVD, reagent FDA UDI
Device Name
A qualitative solubility test kit used to detect the presence of sickling hemoglobins in human blood or sickle cell control material. Contains 250 tests FDA UDI
Model / Reference
GLD-250 FDA UDI
Description
A qualitative solubility test kit used to detect the presence of sickling hemoglobins in human blood or sickle cell control material. Contains 250 tests FDA UDI

Identifiers

Catalog Number
GLD-250 FDA UDI
Primary DI / UDI-DI
00860003629918 FDA UDI
FDA Product Code
GHM FDA UDI
GMDN Term
Haemoglobin S (HbS) IVD, reagent FDA UDI

Classification

Device Class
Class II FDA UDI
Regulation Number
864.7825 FDA UDI
Commercial Distribution
In Commercial Distribution FDA UDI

Clinical & Handling

Sterile

No

FDA UDI

Single Use

No

FDA UDI

Implantable

No

FDA UDI

Contains Latex

No

FDA UDI

Prescription Use

No

FDA UDI

Over-the-Counter

No

FDA UDI

Convenience Kit

Yes

FDA UDI

Combination Product

No

FDA UDI

HCT/P

No

FDA UDI

Premarket Exempt

No

FDA UDI

Lot / Batch Number

Yes

FDA UDI

Serial Number

No

FDA UDI

Expiration Date

Yes

FDA UDI

Manufacturing Date

No

FDA UDI

Category: Haemoglobin S (HbS) IVD, reagent

Sickle-Heme by Great Lakes Diagnostics, Inc. — Class II — FDA UDI — listed in FDA GUDID — regulatory data on deviCERTS

Similar devices

Also classified as Haemoglobin S (HbS) IVD, reagent.

Authorization Coverage (1 country)

Regulatory Authorizations

United States Pending data

FDA UDI

Is this your device? Claim it to add documentation and request validation.

Manufacturer

Sources (1)

  • FDA UDI de44a2af-413c-4d72-8bd9-b1e2226b22c0 35 fields · synced May 29, 2026